Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK)

CUSIP: 035255108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
14,423,417
Total 13F shares
13,538,757
Share change
-37,414
Total reported value
$612,639,033
Put/Call ratio
4%
Price per share
$45.26
Number of holders
156
Value change
+$244,003
Number of buys
57
Number of sells
78

Quarterly Holders Quick Answers

What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) as of Q4 2020

As of 31 Dec 2020, Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) was held by 156 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,538,757 shares. The largest 10 holders included BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Avidity Partners Management LP, Boston Trust Walden Corp, and NORTHERN TRUST CORP. This page lists 156 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.